NTII - Miscellaneous Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NTII - Miscellaneous

NTII 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: John McCarthy	11/5/2005 3:44:49 PM
	of 1296

2005 - OCD and GAD Memantine Trials OCD (Obsessive Compulsive Disorder) If you are over the age of 18 and experience: Recurrent time consuming obsessions or compulsions Persistent thoughts, impulses, or images such as fear of contamination or losing things or excessive worry that something is wrong Repetitive behaviors such as washing, ordering, checking or mental acts such as praying, counting, or repeating words silently Then you may be eligible to participate in a research trial on a study medication (Namenda) for Obsessive Compulsive Disorder. Participants will receive a complete diagnostic evaluation and study medication for 12 weeks, if eligible. centerwatch.com centerwatch.com GAD (General Anxiety Disorder) Summary: UCLA Research Study: Generalized Anxiety Disorder If you are between the ages of 18 and 65 and experience excessive anxiety and worry; accompanied by Restlessness or feeling keyed up or on edge Being easily fatigued Difficulty concentrating or mind going blank Irritability Muscle Tension Sleep Disturbance centerwatch.com centerwatch.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next